Ezekiel discusses the transformative breakthroughs in healthcare since the genome project, highlighting innovations like CRISPR and mRNA technology. He emphasizes the importance of public and private collaboration in research, noting that while government funding is crucial for basic research, it often shies away from high-risk projects. The conversation sheds light on the biases that can influence funding decisions and the need for a balanced approach to clinical research.
